Keywords
Last Name
Institution

Charissa Chang

TitleASSISTANT PROFESSOR
InstitutionMount Sinai
DepartmentLiver Diseases
Address5 East 98th Street
12th Floor
New York NY 10029
Phone212-241-0034
Fax212-289-7738

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Llovet JM, Decaens T, Raoul JL, Boucher E, Kudo M, Chang C, Kang YK, Assenat E, Lim HY, Boige V, Mathurin P, Fartoux L, Lin DY, Bruix J, Poon RT, Sherman M, Blanc JF, Finn RS, Tak WY, Chao Y, Ezzeddine R, Liu D, Walters I, Park JW. Brivanib in Patients With Advanced Hepatocellular Carcinoma Who Were Intolerant to Sorafenib or for Whom Sorafenib Failed: Results From the Randomized Phase III BRISK-PS Study. J Clin Oncol. 2013 Oct 1; 31(28):3509-16.
      View in: PubMed
    2. Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. Int J Hepatol. 2013; 2013:604860.
      View in: PubMed
    3. Perumalswami PV, Factor SH, Kapelusznik L, Friedman SL, Pan CQ, Chang C, Di Clemente F, Dieterich DT. Hepatitis Outreach Network: a practical strategy for hepatitis screening with linkage to care in foreign-born communities. J Hepatol. 2013 May; 58(5):890-7.
      View in: PubMed
    4. Tuyama AC, Chang CY. Non-alcoholic fatty liver disease. J Diabetes. 2012 Sep; 4(3):266-80.
      View in: PubMed
    5. Bhasin D, Zhang X, Ward SC, Chang CY. A case of quadruple viral infections and elevated aminotransferase activities. Semin Liver Dis. 2012 Aug; 32(3):262-6.
      View in: PubMed
    6. Chang CY. Understanding the relationship between PNPLA3, NAFLD and insulin resistance: do ethnic differences bring more questions or more answers? Liver Int. 2011 Oct; 31(9):1246-9.
      View in: PubMed
    7. Chang CY, Martin P, Fotiadu A, Hytiroglou P. A patient with chronic hepatitis B and regression of fibrosis during treatment. Semin Liver Dis. 2010 Aug; 30(3):296-301.
      View in: PubMed
    8. Lachenmayer A, Alsinet C, Chang CY, Llovet JM. Molecular approaches to treatment of hepatocellular carcinoma. Dig Liver Dis. 2010 Jul; 42 Suppl 3:S264-72.
      View in: PubMed
    9. Raja K, Thung SN, Fiel MI, Chang C. Drug-induced steatohepatitis leading to cirrhosis: long-term toxicity of amiodarone use. Semin Liver Dis. 2009 Nov; 29(4):423-8.
      View in: PubMed
    10. Massoumi H, Elsiesy H, Khaitova V, Peterson B, Norkus E, Grewal P, Liu L, Chang C, Bach N, Schiano TD. An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant. Transplantation. 2009 Sep 15; 88(5):729-35.
      View in: PubMed
    11. Ward SC, Chang CY, Peng L, Liu LU. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation. Semin Liver Dis. 2009 May; 29(2):233-7.
      View in: PubMed
    12. Tan HH, Chang CY, Martin P. Acetaminophen hepatotoxicity: current management. Mt Sinai J Med. 2009 Feb; 76(1):75-83.
      View in: PubMed
    13. Chang CY, Singal AK, Ganeshan SV, Schiano TD, Lookstein R, Emre S. Use of splenic artery embolization to relieve tense ascites following liver transplantation in a patient with paroxysmal nocturnal hemoglobinuria. Liver Transpl. 2007 Nov; 13(11):1532-7.
      View in: PubMed
    14. Chang CY, Schiano TD. Review article: drug hepatotoxicity. Aliment Pharmacol Ther. 2007 May 15; 25(10):1135-51.
      View in: PubMed
    15. Chang CY, Argo CK, Al-Osaimi AM, Caldwell SH. Therapy of NAFLD: antioxidants and cytoprotective agents. J Clin Gastroenterol. 2006 Mar; 40 Suppl 1:S51-60.
      View in: PubMed
    Chang's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067